SpliSense is an Israel-based company focused on transformative RNA-based treatments. Our pioneering platform harnesses Antisense Oligonucleotides (ASOs) for treatment of genetic diseases such as Cystic Fibrosis.
Our innovative approach targets unmet needs in genetic pulmonary diseases. SpliSense aims at targeting the root cause of the disease, to overcome specific genetic mutations and restore protein function.
Sponsored Ad
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.